Page last updated: 2024-09-05

sorafenib and Cachexia

sorafenib has been researched along with Cachexia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Huan, Y; Ren, P; Tang, Q; Wang, Y; Xu, J; Xue, C; Yu, X1
Bria, E; Cintoni, M; Gasbarrini, A; Mele, MC; Pompili, M; Ponziani, FR; Pozzo, C; Raoul, P; Rinninella, E; Strippoli, A; Tortora, G1
Argilés, JM; Busquets, S; López-Soriano, FJ; Penna, F; Toledo, M1

Reviews

1 review(s) available for sorafenib and Cachexia

ArticleYear
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges.
    Nutrients, 2020, Oct-12, Volume: 12, Issue:10

    Topics: Cachexia; Humans; Molecular Targeted Therapy; Multicenter Studies as Topic; Muscle, Skeletal; Neoplasms; Nutrition Assessment; Nutritional Status; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Quinolines; Randomized Controlled Trials as Topic; Recommended Dietary Allowances; Sorafenib; Sunitinib; Treatment Outcome

2020

Other Studies

2 other study(ies) available for sorafenib and Cachexia

ArticleYear
Astaxanthin Supplementation Assists Sorafenib in Slowing Skeletal Muscle Atrophy in H22 Tumor-Bearing Mice via Reversing Abnormal Glucose Metabolism.
    Molecular nutrition & food research, 2023, Volume: 67, Issue:16

    Topics: Animals; Cachexia; Dietary Supplements; Glucose; Mice; Muscle, Skeletal; Muscular Atrophy; Phosphatidylinositol 3-Kinases; Sorafenib; Weight Loss

2023
Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3.
    PloS one, 2014, Volume: 9, Issue:12

    Topics: Animals; Antineoplastic Agents; Cachexia; Carcinoma, Lewis Lung; Colon; Colonic Neoplasms; Lung; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscle, Skeletal; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; STAT3 Transcription Factor; Wasting Syndrome

2014